Paul Alpern Sells 4,318 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) VP Paul Alpern sold 4,318 shares of the company’s stock in a transaction on Tuesday, January 6th. The shares were sold at an average price of $16.89, for a total transaction of $72,931.02. Following the completion of the sale, the vice president owned 57,650 shares of the company’s stock, valued at approximately $973,708.50. This trade represents a 6.97% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Arteris Stock Performance

Arteris stock traded down $0.16 during midday trading on Wednesday, hitting $17.42. 353,284 shares of the company’s stock were exchanged, compared to its average volume of 470,696. The firm’s 50 day simple moving average is $15.20 and its 200 day simple moving average is $12.01. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $19.85. The stock has a market cap of $760.98 million, a price-to-earnings ratio of -20.99 and a beta of 1.48.

Arteris (NASDAQ:AIP) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.02. The company had revenue of $17.41 million for the quarter, compared to analysts’ expectations of $17.00 million. On average, equities research analysts forecast that Arteris, Inc. will post -0.73 EPS for the current fiscal year.

Hedge Funds Weigh In On Arteris

Several hedge funds have recently added to or reduced their stakes in the business. Westerly Capital Management LLC lifted its holdings in shares of Arteris by 109.6% in the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock valued at $14,392,000 after purchasing an additional 745,000 shares in the last quarter. Granahan Investment Management LLC raised its position in shares of Arteris by 725.7% during the 3rd quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock worth $6,278,000 after purchasing an additional 546,341 shares during the last quarter. Acadian Asset Management LLC lifted its stake in Arteris by 40.6% in the 1st quarter. Acadian Asset Management LLC now owns 900,723 shares of the company’s stock valued at $6,222,000 after buying an additional 260,277 shares in the last quarter. AQR Capital Management LLC acquired a new stake in Arteris during the 1st quarter valued at $1,621,000. Finally, Roubaix Capital LLC purchased a new position in Arteris during the third quarter worth $2,361,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Rosenblatt Securities restated a “buy” rating and issued a $20.00 price objective on shares of Arteris in a research report on Monday, December 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of Arteris in a research note on Wednesday, October 8th. Wall Street Zen upgraded Arteris from a “sell” rating to a “hold” rating in a research note on Monday, September 15th. Jefferies Financial Group raised Arteris to a “hold” rating in a report on Tuesday, October 28th. Finally, TD Cowen raised their target price on Arteris from $15.00 to $16.50 and gave the company a “buy” rating in a report on Wednesday, November 5th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $17.50.

Trending Headlines about Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Several institutional investors increased or initiated positions (AQR, Acadian, Jacobs Levy, IEQ), signaling continued institutional interest that can support the stock. MarketBeat: Arteris overview
• Neutral Sentiment: Recent quarterly results: Arteris reported EPS of ($0.09) vs. consensus ($0.11) and revenue $17.41M vs. $17.00M — a small beat that supports fundamentals but the company remains unprofitable on a GAAP basis. Analysts have a consensus target ~ $17.50 (Moderate Buy). MarketBeat: Earnings & analyst notes
• Neutral Sentiment: Technical/context: AIP is trading above its 50-day ($15.20) and 200-day ($12.01) moving averages, which can limit downside for some technical traders. MarketBeat: Price data
• Negative Sentiment: Heavy insider selling this week: CEO K. Charles Janac, COO Laurent Moll, CFO Nicholas Hawkins and VP Paul Alpern sold multiple blocks (several thousand shares each) at prices roughly $15.45–$16.89 across Jan. 2–6. Collective insider sales reduce insider ownership and can be interpreted negatively by the market even though insiders still hold sizable stakes. InsiderTrades: Jan 7 summary

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.